Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Phase I study of GRN1005 in recurrent malignant gliomaJan Drappatz, Andrew Brenner, Eric T Wong, et al.Molecular Therapy. Nucleic Acids|July 25, 2013
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular VesiclesWalter W Chen, Leonora Balaj, Linda M Liau, et al.International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiformeJan Drappatz, Eric T Wong, David Schiff, et al.Oncotarget|January 11, 2015
A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastomaFengfei Wang, Marc Remke, Kruttika Bhat, et al.Eclinicalmedicine|March 5, 2026
Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trialsHsien-Chung Chen, Eric T Wong, Sasmit Sarangi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.Neuro-Oncology|February 24, 2016
A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapyEudocia Q Lee, Alona Muzikansky, Jan Drappatz, et al.Neuro-Oncology Advances|December 31, 2025
Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trialNikola Mikic, Slávka Lukacova, Jane Skjøth-Rasmussen, et al.Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.Pageof 13